Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Plos One|February 4, 2012
Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel diseaseTadakazu Hisamatsu, Susumu Okamoto, Masaki Hashimoto, et al.
JCI Insight|October 30, 2025
Myocardial lipin1 protects the heart against ischemic injury by preserving lipid homeostasisJiaxi Guo, Kohei Karasaki, Kazutaka Ueda, et al.
Prostate International|April 11, 2025
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective studyFumihiko Urabe, Hirokazu Kagawa, Takafumi Yanagisawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 16, 2025
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First-Line Platinum-Based Chemotherapy: A Multicenter Collaborative StudyFumihiko Urabe, Kojiro Tashiro, Yu Imai, et al.
Nature Communications|September 7, 2022
Beiging of perivascular adipose tissue regulates its inflammation and vascular remodelingYusuke Adachi, Kazutaka Ueda, Seitaro Nomura, et al.
FEBS Letters|November 15, 2021
The mitochondrial regulator PGC1α is induced by cGMP-PKG signaling and mediates the protective effects of phosphodiesterase 5 inhibition in heart failureGuangshuo Zhu, Kazutaka Ueda, Masaki Hashimoto, et al.
Japanese Journal of Clinical Oncology|January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative studyYuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Clinical Genitourinary Cancer|April 15, 2026
Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter StudyShuhei Hara, Keiichiro Mori, Masaki Hashimoto, et al.
BJU International|July 19, 2025
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Yue Ogihara, et al.
International Journal of Clinical Oncology|December 9, 2025
Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumabMana Nakata, Fumihiko Urabe, Yu Imai, et al.
Pageof 14